These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 36049816)

  • 1. Chemoreflex and Baroreflex Sensitivity Hold a Strong Prognostic Value in Chronic Heart Failure.
    Giannoni A; Gentile F; Buoncristiani F; Borrelli C; Sciarrone P; Spiesshoefer J; Bramanti F; Iudice G; Javaheri S; Emdin M; Passino C
    JACC Heart Fail; 2022 Sep; 10(9):662-676. PubMed ID: 36049816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of baroreflex sensitivity has no prognostic value in contemporary, optimally managed patients with mild-to-moderate heart failure with reduced ejection fraction: a retrospective analysis of 5-year survival.
    Paleczny B; Olesińska-Mader M; Siennicka A; Niewiński P; Nowak K; Buldańczyk A; Jankowska EA; Banasiak W; von Haehling S; Ponikowska B; Anker SD; Ponikowski P
    Eur J Heart Fail; 2019 Jan; 21(1):50-58. PubMed ID: 30191647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Baroreflex sensitivity but not microvolt T-wave alternans can predict major adverse cardiac events in ischemic heart failure.
    Kaufmann DK; Raczak G; Szwoch M; Wabich E; Świątczak M; Daniłowicz-Szymanowicz L
    Cardiol J; 2022; 29(6):1004-1012. PubMed ID: 33001423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central Apneas Are More Detrimental in Female Than in Male Patients With Heart Failure.
    Gentile F; Borrelli C; Sciarrone P; Buoncristiani F; Spiesshoefer J; Bramanti F; Iudice G; Vergaro G; Emdin M; Passino C; Giannoni A
    J Am Heart Assoc; 2022 Mar; 11(5):e024103. PubMed ID: 35191313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators.
    La Rovere MT; Bigger JT; Marcus FI; Mortara A; Schwartz PJ
    Lancet; 1998 Feb; 351(9101):478-84. PubMed ID: 9482439
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic implications of baroreflex sensitivity in heart failure patients in the beta-blocking era.
    La Rovere MT; Pinna GD; Maestri R; Robbi E; Caporotondi A; Guazzotti G; Sleight P; Febo O
    J Am Coll Cardiol; 2009 Jan; 53(2):193-9. PubMed ID: 19130988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arterial baroreflex modulation of heart rate in chronic heart failure: clinical and hemodynamic correlates and prognostic implications.
    Mortara A; La Rovere MT; Pinna GD; Prpa A; Maestri R; Febo O; Pozzoli M; Opasich C; Tavazzi L
    Circulation; 1997 Nov; 96(10):3450-8. PubMed ID: 9396441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Baroreflex sensitivity and heart rate variability in the identification of patients at risk for life-threatening arrhythmias: implications for clinical trials.
    La Rovere MT; Pinna GD; Hohnloser SH; Marcus FI; Mortara A; Nohara R; Bigger JT; Camm AJ; Schwartz PJ;
    Circulation; 2001 Apr; 103(16):2072-7. PubMed ID: 11319197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined increased chemosensitivity to hypoxia and hypercapnia as a prognosticator in heart failure.
    Giannoni A; Emdin M; Bramanti F; Iudice G; Francis DP; Barsotti A; Piepoli M; Passino C
    J Am Coll Cardiol; 2009 May; 53(21):1975-80. PubMed ID: 19460611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heart rate turbulence.
    Cygankiewicz I
    Prog Cardiovasc Dis; 2013; 56(2):160-71. PubMed ID: 24215748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Circulating testosterone and estradiol, autonomic balance and baroreflex sensitivity in middle-aged and elderly men with heart failure.
    Rydlewska A; Maj J; Katkowski B; Biel B; Ponikowska B; Banasiak W; Ponikowski P; Jankowska EA
    Aging Male; 2013 Jun; 16(2):58-66. PubMed ID: 23581721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing baroreflex sensitivity in post-myocardial infarction patients: comparison of spectral and phenylephrine techniques.
    Maestri R; Pinna GD; Mortara A; La Rovere MT; Tavazzi L
    J Am Coll Cardiol; 1998 Feb; 31(2):344-51. PubMed ID: 9462578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Could autonomic nervous system parameters be still helpful in identifying patients with left ventricular systolic dysfunction at the highest risk of all-cause mortality?
    Kaufmann D; Raczak G; Szwoch M; Kozłowski D; Kwiatkowska J; Lewicka E; Daniłowicz-Szymanowicz L
    Cardiol J; 2021; 28(6):914-922. PubMed ID: 31257569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mini Nutritional Assessment Short Form is a morbi-mortality predictor in outpatients with heart failure and mid-range left ventricular ejection fraction.
    Joaquín C; Alonso N; Lupón J; de Antonio M; Domingo M; Moliner P; Zamora E; Codina P; Ramos A; González B; Rivas C; Cachero M; Puig-Domingo M; Bayes-Genis A
    Clin Nutr; 2020 Nov; 39(11):3395-3401. PubMed ID: 32169324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Revisiting the physiological effects of exercise training on autonomic regulation and chemoreflex control in heart failure: does ejection fraction matter?
    Andrade DC; Arce-Alvarez A; Toledo C; Díaz HS; Lucero C; Quintanilla RA; Schultz HD; Marcus NJ; Amann M; Del Rio R
    Am J Physiol Heart Circ Physiol; 2018 Mar; 314(3):H464-H474. PubMed ID: 29167119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Correlation between cardiac autonomic activity and compromise of left ventricular function in dilated cardiomyopathy].
    Hoffmann J; Grimm W; Menz V; Maisch B
    Z Kardiol; 2000 Feb; 89(2):84-92. PubMed ID: 10768276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac diastolic and autonomic dysfunction are aggravated by central chemoreflex activation in heart failure with preserved ejection fraction rats.
    Toledo C; Andrade DC; Lucero C; Arce-Alvarez A; Díaz HS; Aliaga V; Schultz HD; Marcus NJ; Manríquez M; Faúndez M; Del Rio R
    J Physiol; 2017 Apr; 595(8):2479-2495. PubMed ID: 28181258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Baroreflex Activation Therapy in Patients With Heart Failure With Reduced Ejection Fraction.
    Zile MR; Lindenfeld J; Weaver FA; Zannad F; Galle E; Rogers T; Abraham WT
    J Am Coll Cardiol; 2020 Jul; 76(1):1-13. PubMed ID: 32616150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk stratification of mortality in patients with heart failure and left ventricular ejection fraction >35%.
    Cygankiewicz I; Zareba W; Vazquez R; Bayes-Genis A; Pascual D; Macaya C; Almendral J; Fiol M; Bardaji A; Gonzalez-Juanatey JR; Nieto V; Valdes M; Cinca J; de Luna AB;
    Am J Cardiol; 2009 Apr; 103(7):1003-10. PubMed ID: 19327431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spontaneous baroreceptor reflex sensitivity for risk stratification of heart failure patients: optimal cut-off and age effects.
    Gouveia S; Scotto MG; Pinna GD; Maestri R; La Rovere MT; Ferreira PJ
    Clin Sci (Lond); 2015 Dec; 129(12):1163-72. PubMed ID: 26432088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.